(Q51143326)

31 March 2018

title

High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. (English)

1 reference

31 March 2018

author

Chia-Chyi Liu

1

1 reference

31 March 2018

Michael Butler

object named as

Michael Butler

3

0 references

author name string

Wei-Cheng Lian

2

1 reference

31 March 2018

Suh-Chin Wu

4

1 reference

31 March 2018

language of work or name

English

0 references

publication date

2 August 2006

1 reference

31 March 2018

published in

Vaccine

1 reference

31 March 2018

volume

25

1 reference

31 March 2018

issue

1

1 reference

31 March 2018

page(s)

19-24

1 reference

31 March 2018

An apparently new enterovirus isolated from patients with disease of the central nervous system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

An overview of the evolution of enterovirus 71 and its clinical and public health significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Change of major genotype of enterovirus 71 in outbreaks of hand-foot-and-mouth disease in Taiwan between 1998 and 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Enterovirus 71 outbreaks, Taiwan: occurrence and recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Molecular epidemiology of enterovirus 71 infection in the Western Pacific Region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Growth of Cell-strains and Primary Cells on Micro-carriers in Homogeneous Culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Avoiding viral contamination in biotechnological and pharmaceutical processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (Requirements for biological susbstances no. 50).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Evaluation of the serum-free medium MDSS2 for the production of poliovirus on vero cells in bioreactors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Application of a serum-free medium for the growth of Vero cells and the production of reovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Stationary and microcarrier cell culture processes for propagating Japanese encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Vero-cell rabies vaccine produced using serum-free medium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.083

10.1016/J.VACCINE.2006.06.083

7 January 2021

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018